Jeffrey Dean, MD
Orthopaedic Surgery · San Antonio, TXNPI 1497848055
Payments from drug & device makers
What this record shows
This record is dominated by education: $2,507 of the $3,951 with a category attached, or 63.5%. Medinc Of Texas accounts for 63.5% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2021 at $1,420 and has fallen 94.8% since, to $74 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in TX, where the typical reported total is $4,671.
Across 42 payments — averaging $94.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medinc Of Texas$3K
- Amgen$381
- Smith+Nephew$295
- Stryker$287
- Acumed LLC$129
- Miach Orthopaedics, Inc.$109
- plus $243 from 9 others
What the payments were for
- Food & beverage$1,44437%
- Education$2,50763%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medinc Of Texas | 2 | $2,507 |
| Amgen(2 entities) | 9 | $381 |
| Smith+Nephew | 5 | $295 |
| Stryker | 7 | $287 |
| Acumed LLC | 2 | $129 |
| Miach Orthopaedics, Inc. | 1 | $109 |
| Ferring Pharmaceuticals Inc. | 6 | $102 |
| Pacira Pharmaceuticals Incorporated | 2 | $26 |
| Vericel Corporation | 1 | $25 |
| Anika Therapeutics, Inc. | 1 | $24 |
| Theragen, Inc. | 1 | $19 |
| Deroyal Industries, Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Fidia Pharma USA Inc. | 2 | $13 |
| ERMI LLC | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,951 in reported general payments places this provider in the 45th percentile of 1,337 orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 22 | $492 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $176 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 15 | $123 |
| Promethazine Hcl | 21 | $71 |
| Ibuprofen | 11 | $39 |
| Meloxicam | 11 | $34 |
| Tramadol Hcl | 16 | $32 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in San Antonio
- Stephen BurkhartSan Antonio$185.3M
- Michael WirthSan Antonio$4.5M
- Ravi KariaSan Antonio$1.1M
- Charles RockwoodSan Antonio$975K
- Christopher ChaputSan Antonio$959K
- Frank ButtacavoliSan Antonio$866K
- Robert HartzlerSan Antonio$654K
- Bernard MorreySan Antonio$639K
- Animesh AgarwalSan Antonio$408K
- Ralph GarzaSan Antonio$390K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.